Prediction of Medication Compliance Following Renal Transplantation

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Completed

Conditions

Kidney Transplantation

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00148187
2P01DK013083-40A1 (U.S. NIH Grant/Contract)
0202M17442

Details and patient eligibility

About

The purpose of this study is to quantitate pre-transplant medication compliance, dialysis compliance, and related psychological variables, and then examine their validity as predictors of post-transplant noncompliant behaviors and clinically relevant outcomes (acute rejection, graft loss, or death). Hypothesis: Noncompliance with pre-transplant medication or with the dialysis prescription, and specific psychological variables predict similarly noncompliant behaviors after transplantation.

Full description

This pilot study is intended to provide preliminary data about the feasibility of recruiting a cohort of subjects on hemodialysis and following them prospectively through the transplant procedure. The study will document patient adherence to medications and treatment, both before and after surgery. These preliminary data will permit appropriate design and power calculations for a future study assessing our ability to predict post-transplant compliance, based on pre-transplant behaviors.

Enrollment

30 patients

Sex

All

Ages

14+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult hemodialysis patients in renal transplant evaluation
  • Able to read test forms
  • Responsible for their own medications

Exclusion criteria

  • Patients with a major risk of recurrent primary renal disease, e.g. hemolytic uremic syndrome, oxalosis, membranoproliferative glomerulonephritis type II, focal segmental glomerulosclerosis with nephrotic syndrome.
  • Patients with active psychosis
  • Patients who do not speak English.
  • Patients who live and will be followed outside the United States, except Canada.
  • Patients who are physically unable to open the Medication Event Monitoring System (MEMS) cap.
  • Patients who are not responsible for taking their own medications, e.g. living in a medical care facility.
  • Patients who are younger than 14 years old
  • Patients who will receive an extra renal organ (except pancreas), either simultaneously or previously.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems